Top Markets
#1 Cortex Cortex +173.85%
#2 GEKKO GEKKO +52.86%
#3 Audiera Audiera +20.07%
#4 ADO Protocol ADO Protocol +17.27%
#5 Seeker Seeker +16.11%
#6 o1.exchange o1.exchange +12.87%
#7 Status Status +9.82%
#8 OpenGradient OpenGradient +9.53%
#9 Pons Pons +9.24%
#10 Helium Helium +8.90%
Coin of the day
Cortex Cortex
설정
언어
한국어
통화
USD
테마
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
주식 순위 #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
주가
$59.98
마지막 동기화: 2024-12-13
시가총액
$1.22B
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Longboard Pharmaceuticals, Inc. (LBPH)

카테고리

Healthcare
Longboard Pharmaceuticals, Inc. (LBPH)의 수익
Sep 2024 기준 수익 TTM: $-76.34M
Longboard Pharmaceuticals, Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익은 $-76.34M입니다. 2022년에 회사는 $-43.95M의 수익을 올렸으며 이는 2021년의 수익 $-27.80M과 감소입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
Longboard Pharmaceuticals, Inc.의 수익 기록 (2020 ~ 2026)
연말 수익
연도 수익 변화
2026 (TTM) $-76.34M 40.28%
2023 $-54.42M 23.84%
2022 $-43.95M 58.09%
2021 $-27.80M 93.03%
2020 $-14.40M 0.00%
유사 기업 또는 경쟁사의 수익
회사 수익 수익 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -7,009.38%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -2,655.08%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B 5,160.66%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B 3,943.54%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH